| Filed On | Filing |
|---|---|
| 13 May 2026 |
8-K/A: Other Events
On February 20, 2026, iMDx announced that it had entered into a Specimen Collection Agreement with Quest Diagnostics for certain specimen collection-related services related to the Company’s GraftAssureCoreTM test, a blood test designed ... |
| 10 Oct 2023 |
8-K/A: Changes in Registrant's Certifying Accountant
As previously reported on a Current Report on Form 8-K filed on October 5, 2023 by Oncocyte Corporation (the “Company”), the Audit Committee of the Company’s Board of Directors approved the engagement of Marcum LLP (“Marcum”) as the Comp... |
| 17 Feb 2023 |
8-K/A: Submission of Matters to a Vote of Security Holders
As reported in the Original Report, at the Meeting, the shareholders of the Company voted on a proposal (“Proposal No. 5”) to approve an amendment (the “Plan Amendment”) to the Company’s 2018 Equity Incentive Plan (the “Incentive Plan”) ... |
| 01 Jun 2021 | 8-K/A: Financial Statements and Exhibits |
| 17 Mar 2020 | 8-K/A: Financial Statements and Exhibits |
| 05 Sep 2019 | 8-K/A: Financial Statements and Exhibits |
Loading...
